PL1638582T3 - Zastosowanie kwasu hialuronowego do wytwarzania środków do leczenia nawracających aft w jamie ustnej - Google Patents

Zastosowanie kwasu hialuronowego do wytwarzania środków do leczenia nawracających aft w jamie ustnej

Info

Publication number: PL1638582T3
Authority: PL; Poland
Prior art keywords: aphthas; hyaluronic acid; oral cavity; preparing compositions; recurrent oral
Prior art date: 2003-06-25

Application number

PL04766068T

Other languages

English (en)

Inventor

Franco Macchi

Original Assignee

Bioplax Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-25

Filing date

2004-06-23

Publication date

2009-07-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30131290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1638582(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-06-23 Application filed by Bioplax Ltd filed Critical Bioplax Ltd

2009-07-31 Publication of PL1638582T3 publication Critical patent/PL1638582T3/pl

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 2
208000002399 aphthous stomatitis Diseases 0.000 title abstract 2
229920002674 hyaluronan Polymers 0.000 title abstract 2
229960003160 hyaluronic acid Drugs 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
210000000214 mouth Anatomy 0.000 title abstract 2
230000000306 recurrent effect Effects 0.000 title 1
239000004480 active ingredient Substances 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oral & Maxillofacial Surgery (AREA)
Molecular Biology (AREA)
Birds (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL04766068T 2003-06-25 2004-06-23 Zastosowanie kwasu hialuronowego do wytwarzania środków do leczenia nawracających aft w jamie ustnej PL1638582T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IT001291A ITMI20031291A1 (it)	2003-06-25	2003-06-25	Uso di acido ialuronico per la preparazione di composizioni per il trattamento di afte del cavo orale.
EP04766068A EP1638582B1 (en)	2003-06-25	2004-06-23	Use of hyaluronic acid for preparing compositions for treating recurrent oral cavity aphthas
PCT/EP2004/051209 WO2005000321A1 (en)	2003-06-25	2004-06-23	Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas

Publications (1)

Publication Number	Publication Date
PL1638582T3 true PL1638582T3 (pl)	2009-07-31

Family

ID=30131290

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04766068T PL1638582T3 (pl)	2003-06-25	2004-06-23	Zastosowanie kwasu hialuronowego do wytwarzania środków do leczenia nawracających aft w jamie ustnej

Country Status (17)

Country	Link
US (1)	US10245280B2 (pl)
EP (1)	EP1638582B1 (pl)
JP (1)	JP4728955B2 (pl)
CN (1)	CN1812798B (pl)
AT (1)	ATE422892T1 (pl)
BR (1)	BRPI0411702B8 (pl)
CA (1)	CA2529441C (pl)
CY (1)	CY1108992T1 (pl)
DE (1)	DE602004019528D1 (pl)
DK (1)	DK1638582T3 (pl)
ES (1)	ES2322060T3 (pl)
IT (1)	ITMI20031291A1 (pl)
MX (1)	MXPA05014184A (pl)
PL (1)	PL1638582T3 (pl)
PT (1)	PT1638582E (pl)
SI (1)	SI1638582T1 (pl)
WO (1)	WO2005000321A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100518152B1 (ko) *	2002-05-09	2005-09-29	메디제네스(주)	혈장 또는 혈청을 함유한 창상 치료용 약학 조성물
US7323184B2 (en) *	2005-08-22	2008-01-29	Healagenics, Inc.	Compositions and methods for the treatment of wounds and the reduction of scar formation
ITMI20081450A1 (it) *	2008-08-04	2010-02-05	Biofarmitalia Spa	Pellicola solida a rapida dissoluzione nei liquidi
IT1396468B1 (it) *	2008-11-11	2012-12-14	Farma Derma Srl	Uso topico di acido ialuronico ad azione filmogena in preparati per il trattamento e profilassi di patologie delle vie respiratorie.
ES2388281B1 (es)	2010-12-27	2013-10-01	Laboratorios Viñas S.A.	Composición farmacéutica que comprende ácido hialurónico y un compuesto de zinc y pastilla con palito y procedimiento para preparación correspondientes
JP5840107B2 (ja) *	2012-06-17	2016-01-06	コスメディ製薬株式会社	ヒアルロン酸ゲル及びその製造方法
CN103860526A (zh) *	2013-11-26	2014-06-18	华熙福瑞达生物医药有限公司	一种含透明质酸的消毒剂、其制备方法及用途
EP3056195A1 (en)	2015-02-13	2016-08-17	Vision:Organic GmbH	Compositions comprising hyaluronic acid and beta-glucan for topical applications in oral cavity
ITUB20153699A1 (it) *	2015-09-17	2017-03-17	Fastmeditalia Srl	Integratore orale
IT201700048750A1 (it) *	2017-05-05	2018-11-05	Farm Procemsa S P A	Composizione per il trattamento di afte e ulcere buccali
GB201713362D0 (en) *	2017-08-21	2017-10-04	Givaudan Sa	Improvements in or relating to organic compounds
CN108210689A (zh) *	2017-11-27	2018-06-29	南京天纵易康生物科技股份有限公司	一种含有透明质酸的口腔溃疡膜剂及其制备方法
EP4230212A1 (en)	2022-02-16	2023-08-23	UNIVERSITÄTSmedizin der Johannes Gutenberg- Universität Mainz	Composition and kits for the prevention or treatment of gum diseases
IT202200010439A1 (it) *	2022-05-19	2023-11-19	Anatek Health Italia S R L	Composizione comprendente acido nevronico e beta-cariofillene nel trattamento della mucosite

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US183278A (en)		1876-10-17		Improvement in ventilating-cowls
IT1240316B (it)	1990-02-21	1993-12-07	Ricerca Di Schiena Del Dr. Michele G. Di Schiema & C.	Composizioni a base di acido ialuronico ad alto peso molecolare somministrabili per via topica per il trattamento di infiammazioni del cavo orale ,per la cosmetica e l'igiene del cavo orale
US5972906A (en) *	1991-07-03	1999-10-26	Hyal Pharmaceutical Corporation	Treatment of mucous membrane disease, trauma or condition and for the relief of pain thereof
IT1318649B1 (it)	2000-07-28	2003-08-27	Propharma S R L Ora Sinclair P	Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
US6828308B2 (en) *	2000-07-28	2004-12-07	Sinclair Pharmaceuticals, Ltd.	Compositions and methods for the treatment or prevention of inflammation

2003
- 2003-06-25 IT IT001291A patent/ITMI20031291A1/it unknown
2004
- 2004-06-23 ES ES04766068T patent/ES2322060T3/es not_active Expired - Lifetime
- 2004-06-23 DK DK04766068T patent/DK1638582T3/da active
- 2004-06-23 US US10/561,670 patent/US10245280B2/en not_active Expired - Lifetime
- 2004-06-23 CA CA2529441A patent/CA2529441C/en not_active Expired - Fee Related
- 2004-06-23 CN CN200480017686XA patent/CN1812798B/zh not_active Expired - Fee Related
- 2004-06-23 EP EP04766068A patent/EP1638582B1/en not_active Expired - Lifetime
- 2004-06-23 BR BRPI0411702A patent/BRPI0411702B8/pt not_active IP Right Cessation
- 2004-06-23 WO PCT/EP2004/051209 patent/WO2005000321A1/en not_active Ceased
- 2004-06-23 DE DE602004019528T patent/DE602004019528D1/de not_active Expired - Lifetime
- 2004-06-23 PT PT04766068T patent/PT1638582E/pt unknown
- 2004-06-23 PL PL04766068T patent/PL1638582T3/pl unknown
- 2004-06-23 JP JP2006516177A patent/JP4728955B2/ja not_active Expired - Fee Related
- 2004-06-23 AT AT04766068T patent/ATE422892T1/de active
- 2004-06-23 MX MXPA05014184A patent/MXPA05014184A/es active IP Right Grant
- 2004-06-23 SI SI200431112T patent/SI1638582T1/sl unknown
2009
- 2009-05-07 CY CY20091100491T patent/CY1108992T1/el unknown

Also Published As

Publication number	Publication date
CY1108992T1 (el)	2014-07-02
CN1812798A (zh)	2006-08-02
BRPI0411702B1 (pt)	2019-08-13
ES2322060T3 (es)	2009-06-16
ITMI20031291A1 (it)	2004-12-26
BRPI0411702A (pt)	2006-08-08
JP4728955B2 (ja)	2011-07-20
ATE422892T1 (de)	2009-03-15
US10245280B2 (en)	2019-04-02
PT1638582E (pt)	2009-05-28
WO2005000321A1 (en)	2005-01-06
MXPA05014184A (es)	2006-03-09
EP1638582B1 (en)	2009-02-18
DE602004019528D1 (de)	2009-04-02
ITMI20031291A0 (it)	2003-06-25
CA2529441C (en)	2012-12-04
EP1638582A1 (en)	2006-03-29
US20060147393A1 (en)	2006-07-06
DK1638582T3 (da)	2009-05-18
BRPI0411702B8 (pt)	2021-05-25
CA2529441A1 (en)	2005-01-06
SI1638582T1 (sl)	2009-10-31
JP2009513492A (ja)	2009-04-02
CN1812798B (zh)	2011-02-09

Similar Documents

Publication	Publication Date	Title
MY144992A (en)	2011-12-15	Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
MY143795A (en)	2011-07-15	Tetrahydropyridoindole derivatives
TW200605870A (en)	2006-02-16	Topical methadone compositions and methods for using the same
TW200500358A (en)	2005-01-01	Compounds
MXPA05009694A (es)	2005-10-20	Metodos para mejorar la calidad de la piel.
CY1108992T1 (el)	2014-07-02	Η χρηση του υαλουρονικου οξεος για την παρασκευη συνθεσεων για τη θεραπευτικη αντιμετωπιση υποτροπιαζουσων αφθων της στοματικης κοιλοτητας
PL1654253T3 (pl)	2007-05-31	Podstawione pochodne 3-pirolidynoindolu
AU3850600A (en)	2000-10-04	Dalda analogs and their use
TW200514772A (en)	2005-05-01	Novel tetrahydropyridine derivatives
MXPA04001256A (es)	2004-05-27	Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
TW200716628A (en)	2007-05-01	Novel compounds
DE602005021770D1 (de)	2010-07-22	Indol-1-yl-essigsäurederivate
MXPA05013549A (es)	2006-04-05	Derivados de tienopirimidina como inhibidores del canal de potasio.
MY135850A (en)	2008-07-31	Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
UA86776C2 (ru)	2009-05-25	Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и применение
TW200504029A (en)	2005-02-01	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
UA83821C2 (ru)	2008-08-26	Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
UA83832C2 (ru)	2008-08-26	Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и их применение
TW200626581A (en)	2006-08-01	Compounds, compositions containing them, preparation thereof and uses thereof
TW200503785A (en)	2005-02-01	Dosage form containing (S)-pantoprazole as active ingredient
MXPA06007007A (es)	2007-06-08	Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
TW200640465A (en)	2006-12-01	New pharmaceutically active compounds for the treatment of respiratory diseases
WO2002051404A8 (fr)	2003-11-13	Compositions orales
PL1874410T3 (pl)	2009-07-31	Odbarwiająca lub rozjaśniająca kompozycja kosmetyczna zawierająca co najmniej jedną oksazolinę jako składnik aktywny
PL369845A1 (pl)	2005-05-02	Zastosowanie pochodnych kwasu 4-oksobutanowego w leczeniu stanów zapalnych